APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peramivir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Peramivir Market Analysis and Forecast 2026-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchPeramivir Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Peramivir Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Peramivir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peramivir Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Peramivir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Peramivir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Peramivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Peramivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Peramivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Peramivir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Peramivir include BioCryst Pharmaceuticals, Green Cross Pharma, Hikma Pharmaceuticals, Moksha8 Pharma, NeoPharm, NT Pharma, SCOLR Pharma, Hunan Nucien Pharmaceutical Co., Ltd. and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Peramivir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Peramivir, also provides the sales of main regions and countries. Of the upcoming market potential for Peramivir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peramivir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Peramivir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Peramivir sales, projected growth trends, production technology, application and end-user industry.

Peramivir Segment by Company

BioCryst Pharmaceuticals

Green Cross Pharma

Hikma Pharmaceuticals

Moksha8 Pharma

NeoPharm

NT Pharma

SCOLR Pharma

Hunan Nucien Pharmaceutical Co., Ltd.

Merck

Shionogi Co.

Peramivir Segment by Type

Solution

Solid

Peramivir Segment by Application

Influenza A Treatment

Influenza B Treatment

Peramivir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peramivir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peramivir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peramivir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Peramivir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Peramivir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peramivir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Peramivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solution Major Manufacturers Table 3. Solid Major Manufacturers Table 4. Global Peramivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Influenza A Treatment Major Manufacturers Table 6. Influenza B Treatment Major Manufacturers Table 7. Peramivir Industry Trends Table 8. Peramivir Industry Drivers Table 9. Peramivir Industry Opportunities and Challenges Table 10. Peramivir Industry Restraints Table 11. Global Peramivir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Peramivir Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Peramivir Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Peramivir Revenue Market Share by Region (2021-2026) Table 15. Global Peramivir Revenue Market Share by Region (2027-2032) Table 16. Global Peramivir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 17. Global Peramivir Sales by Region (2021-2026) & (Tons) Table 18. Global Peramivir Sales by Region (2027-2032) & (Tons) Table 19. Global Peramivir Sales Market Share by Region (2021-2026) Table 20. Global Peramivir Sales Market Share by Region (2027-2032) Table 21. Global Peramivir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Peramivir Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Peramivir Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Peramivir Sales Market Share by Manufacturers (2021-2026) Table 25. Global Peramivir Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 26. Global Peramivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Peramivir Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Peramivir Manufacturers, Product Type & Application Table 29. Global Peramivir Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Peramivir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Peramivir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Peramivir Revenue Market Share by Type (2021-2026) Table 36. Global Peramivir Revenue Market Share by Type (2027-2032) Table 37. Global Peramivir Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 38. Global Peramivir Sales by Type (2021-2026) & (Tons) Table 39. Global Peramivir Sales by Type (2027-2032) & (Tons) Table 40. Global Peramivir Sales Market Share by Type (2021-2026) Table 41. Global Peramivir Sales Market Share by Type (2027-2032) Table 42. Global Peramivir Price by Type (2021-2026) & (US$/Kg) Table 43. Global Peramivir Price by Type (2027-2032) & (US$/Kg) Table 44. Global Peramivir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Peramivir Revenue Market Share by Application (2021-2026) Table 48. Global Peramivir Revenue Market Share by Application (2027-2032) Table 49. Global Peramivir Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 50. Global Peramivir Sales by Application (2021-2026) & (Tons) Table 51. Global Peramivir Sales by Application (2027-2032) & (Tons) Table 52. Global Peramivir Sales Market Share by Application (2021-2026) Table 53. Global Peramivir Sales Market Share by Application (2027-2032) Table 54. Global Peramivir Price by Application (2021-2026) & (US$/Kg) Table 55. Global Peramivir Price by Application (2027-2032) & (US$/Kg) Table 56. BioCryst Pharmaceuticals Company Information Table 57. BioCryst Pharmaceuticals Business Overview Table 58. BioCryst Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 59. BioCryst Pharmaceuticals Peramivir Product Portfolio Table 60. BioCryst Pharmaceuticals Recent Development Table 61. Green Cross Pharma Company Information Table 62. Green Cross Pharma Business Overview Table 63. Green Cross Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 64. Green Cross Pharma Peramivir Product Portfolio Table 65. Green Cross Pharma Recent Development Table 66. Hikma Pharmaceuticals Company Information Table 67. Hikma Pharmaceuticals Business Overview Table 68. Hikma Pharmaceuticals Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. Hikma Pharmaceuticals Peramivir Product Portfolio Table 70. Hikma Pharmaceuticals Recent Development Table 71. Moksha8 Pharma Company Information Table 72. Moksha8 Pharma Business Overview Table 73. Moksha8 Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Moksha8 Pharma Peramivir Product Portfolio Table 75. Moksha8 Pharma Recent Development Table 76. NeoPharm Company Information Table 77. NeoPharm Business Overview Table 78. NeoPharm Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. NeoPharm Peramivir Product Portfolio Table 80. NeoPharm Recent Development Table 81. NT Pharma Company Information Table 82. NT Pharma Business Overview Table 83. NT Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. NT Pharma Peramivir Product Portfolio Table 85. NT Pharma Recent Development Table 86. SCOLR Pharma Company Information Table 87. SCOLR Pharma Business Overview Table 88. SCOLR Pharma Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. SCOLR Pharma Peramivir Product Portfolio Table 90. SCOLR Pharma Recent Development Table 91. Hunan Nucien Pharmaceutical Co., Ltd. Company Information Table 92. Hunan Nucien Pharmaceutical Co., Ltd. Business Overview Table 93. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio Table 95. Hunan Nucien Pharmaceutical Co., Ltd. Recent Development Table 96. Merck Company Information Table 97. Merck Business Overview Table 98. Merck Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Merck Peramivir Product Portfolio Table 100. Merck Recent Development Table 101. Shionogi Co. Company Information Table 102. Shionogi Co. Business Overview Table 103. Shionogi Co. Peramivir Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Shionogi Co. Peramivir Product Portfolio Table 105. Shionogi Co. Recent Development Table 106. North America Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Peramivir Sales by Type (2021-2026) & (Tons) Table 109. North America Peramivir Sales by Type (2027-2032) & (Tons) Table 110. North America Peramivir Sales Price by Type (2021-2026) & (US$/Kg) Table 111. North America Peramivir Sales Price by Type (2027-2032) & (US$/Kg) Table 112. North America Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Peramivir Sales by Application (2021-2026) & (Tons) Table 115. North America Peramivir Sales by Application (2027-2032) & (Tons) Table 116. North America Peramivir Sales Price by Application (2021-2026) & (US$/Kg) Table 117. North America Peramivir Sales Price by Application (2027-2032) & (US$/Kg) Table 118. North America Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Peramivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Peramivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Peramivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 122. North America Peramivir Sales by Country (2021-2026) & (Tons) Table 123. North America Peramivir Sales by Country (2027-2032) & (Tons) Table 124. North America Peramivir Sales Price by Country (2021-2026) & (US$/Kg) Table 125. North America Peramivir Sales Price by Country (2027-2032) & (US$/Kg) Table 126. United States Peramivir Revenue (2021-2032) & (US$ Million) Table 127. Canada Peramivir Revenue (2021-2032) & (US$ Million) Table 128. Europe Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Peramivir Sales by Type (2021-2026) & (Tons) Table 131. Europe Peramivir Sales by Type (2027-2032) & (Tons) Table 132. Europe Peramivir Sales Price by Type (2021-2026) & (US$/Kg) Table 133. Europe Peramivir Sales Price by Type (2027-2032) & (US$/Kg) Table 134. Europe Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Peramivir Sales by Application (2021-2026) & (Tons) Table 137. Europe Peramivir Sales by Application (2027-2032) & (Tons) Table 138. Europe Peramivir Sales Price by Application (2021-2026) & (US$/Kg) Table 139. Europe Peramivir Sales Price by Application (2027-2032) & (US$/Kg) Table 140. Europe Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Peramivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Peramivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Peramivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 144. Europe Peramivir Sales by Country (2021-2026) & (Tons) Table 145. Europe Peramivir Sales by Country (2027-2032) & (Tons) Table 146. Europe Peramivir Sales Price by Country (2021-2026) & (US$/Kg) Table 147. Europe Peramivir Sales Price by Country (2027-2032) & (US$/Kg) Table 148. Germany Peramivir Revenue (2021-2032) & (US$ Million) Table 149. France Peramivir Revenue (2021-2032) & (US$ Million) Table 150. U.K. Peramivir Revenue (2021-2032) & (US$ Million) Table 151. Italy Peramivir Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Peramivir Revenue (2021-2032) & (US$ Million) Table 153. China Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 154. China Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 155. China Peramivir Sales by Type (2021-2026) & (Tons) Table 156. China Peramivir Sales by Type (2027-2032) & (Tons) Table 157. China Peramivir Sales Price by Type (2021-2026) & (US$/Kg) Table 158. China Peramivir Sales Price by Type (2027-2032) & (US$/Kg) Table 159. China Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 160. China Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 161. China Peramivir Sales by Application (2021-2026) & (Tons) Table 162. China Peramivir Sales by Application (2027-2032) & (Tons) Table 163. China Peramivir Sales Price by Application (2021-2026) & (US$/Kg) Table 164. China Peramivir Sales Price by Application (2027-2032) & (US$/Kg) Table 165. Asia Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Peramivir Sales by Type (2021-2026) & (Tons) Table 168. Asia Peramivir Sales by Type (2027-2032) & (Tons) Table 169. Asia Peramivir Sales Price by Type (2021-2026) & (US$/Kg) Table 170. Asia Peramivir Sales Price by Type (2027-2032) & (US$/Kg) Table 171. Asia Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Peramivir Sales by Application (2021-2026) & (Tons) Table 174. Asia Peramivir Sales by Application (2027-2032) & (Tons) Table 175. Asia Peramivir Sales Price by Application (2021-2026) & (US$/Kg) Table 176. Asia Peramivir Sales Price by Application (2027-2032) & (US$/Kg) Table 177. Asia Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Peramivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Peramivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Peramivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 181. Asia Peramivir Sales by Country (2021-2026) & (Tons) Table 182. Asia Peramivir Sales by Country (2027-2032) & (Tons) Table 183. Asia Peramivir Sales Price by Country (2021-2026) & (US$/Kg) Table 184. Asia Peramivir Sales Price by Country (2027-2032) & (US$/Kg) Table 185. Japan Peramivir Revenue (2021-2032) & (US$ Million) Table 186. South Korea Peramivir Revenue (2021-2032) & (US$ Million) Table 187. India Peramivir Revenue (2021-2032) & (US$ Million) Table 188. Australia Peramivir Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Peramivir Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Peramivir Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Peramivir Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Peramivir Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Peramivir Sales by Type (2021-2026) & (Tons) Table 194. SAMEA Peramivir Sales by Type (2027-2032) & (Tons) Table 195. SAMEA Peramivir Sales Price by Type (2021-2026) & (US$/Kg) Table 196. SAMEA Peramivir Sales Price by Type (2027-2032) & (US$/Kg) Table 197. SAMEA Peramivir Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Peramivir Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Peramivir Sales by Application (2021-2026) & (Tons) Table 200. SAMEA Peramivir Sales by Application (2027-2032) & (Tons) Table 201. SAMEA Peramivir Sales Price by Application (2021-2026) & (US$/Kg) Table 202. SAMEA Peramivir Sales Price by Application (2027-2032) & (US$/Kg) Table 203. SAMEA Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Peramivir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Peramivir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Peramivir Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 207. SAMEA Peramivir Sales by Country (2021-2026) & (Tons) Table 208. SAMEA Peramivir Sales by Country (2027-2032) & (Tons) Table 209. SAMEA Peramivir Sales Price by Country (2021-2026) & (US$/Kg) Table 210. SAMEA Peramivir Sales Price by Country (2027-2032) & (US$/Kg) Table 211. Brazil Peramivir Revenue (2021-2032) & (US$ Million) Table 212. Argentina Peramivir Revenue (2021-2032) & (US$ Million) Table 213. Chile Peramivir Revenue (2021-2032) & (US$ Million) Table 214. Colombia Peramivir Revenue (2021-2032) & (US$ Million) Table 215. Peru Peramivir Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Peramivir Revenue (2021-2032) & (US$ Million) Table 217. Israel Peramivir Revenue (2021-2032) & (US$ Million) Table 218. UAE Peramivir Revenue (2021-2032) & (US$ Million) Table 219. Turkey Peramivir Revenue (2021-2032) & (US$ Million) Table 220. Iran Peramivir Revenue (2021-2032) & (US$ Million) Table 221. Egypt Peramivir Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Peramivir Distributors List Table 225. Peramivir Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Peramivir Image Figure 2. Global Peramivir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peramivir Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solution Image Figure 5. Solid Image Figure 6. Global Peramivir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Peramivir Market Size Share 2021 VS 2025 VS 2032 Figure 8. Influenza A Treatment Image Figure 9. Influenza B Treatment Image Figure 10. Global Peramivir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Peramivir Revenue (2021-2032) & (US$ Million) Figure 12. Global Peramivir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Peramivir Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Peramivir Revenue Market Share by Region (2021-2032) Figure 15. Global Peramivir Sales (2021-2032) & (Tons) Figure 16. Global Peramivir Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 17. Global Peramivir Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Peramivir Sales YoY (2021-2032) & (Tons) Figure 19. Europe Peramivir Sales YoY (2021-2032) & (Tons) Figure 20. China Peramivir Sales YoY (2021-2032) & (Tons) Figure 21. Asia (Excluding China) Peramivir Sales YoY (2021-2032) & (Tons) Figure 22. South America, Middle East and Africa Peramivir Sales YoY (2021-2032) & (Tons) Figure 23. Global Peramivir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Peramivir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Peramivir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Peramivir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Peramivir Revenue Market Share by Type (2021-2032) Figure 29. Global Peramivir Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 30. Global Peramivir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Peramivir Sales Market Share by Type (2021-2032) Figure 32. Global Peramivir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Peramivir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Peramivir Revenue Market Share by Application (2021-2032) Figure 35. Global Peramivir Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 36. Global Peramivir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Peramivir Sales Market Share by Application (2021-2032) Figure 38. North America Peramivir Revenue Share by Type (2021-2032) Figure 39. North America Peramivir Sales Share by Type (2021-2032) Figure 40. North America Peramivir Revenue Share by Application (2021-2032) Figure 41. North America Peramivir Sales Share by Application (2021-2032) Figure 42. North America Peramivir Revenue Share by Country (2021-2032) Figure 43. North America Peramivir Sales Share by Country (2021-2032) Figure 44. Europe Peramivir Revenue Share by Type (2021-2032) Figure 45. Europe Peramivir Sales Share by Type (2021-2032) Figure 46. Europe Peramivir Revenue Share by Application (2021-2032) Figure 47. Europe Peramivir Sales Share by Application (2021-2032) Figure 48. Europe Peramivir Revenue Share by Country (2021-2032) Figure 49. Europe Peramivir Sales Share by Country (2021-2032) Figure 50. China Peramivir Revenue Share by Type (2021-2032) Figure 51. China Peramivir Sales Share by Type (2021-2032) Figure 52. China Peramivir Revenue Share by Application (2021-2032) Figure 53. China Peramivir Sales Share by Application (2021-2032) Figure 54. Asia Peramivir Revenue Share by Type (2021-2032) Figure 55. Asia Peramivir Sales Share by Type (2021-2032) Figure 56. Asia Peramivir Revenue Share by Application (2021-2032) Figure 57. Asia Peramivir Sales Share by Application (2021-2032) Figure 58. Asia Peramivir Revenue Share by Country (2021-2032) Figure 59. Asia Peramivir Sales Share by Country (2021-2032) Figure 60. SAMEA Peramivir Revenue Share by Type (2021-2032) Figure 61. SAMEA Peramivir Sales Share by Type (2021-2032) Figure 62. SAMEA Peramivir Revenue Share by Application (2021-2032) Figure 63. SAMEA Peramivir Sales Share by Application (2021-2032) Figure 64. SAMEA Peramivir Revenue Share by Country (2021-2032) Figure 65. SAMEA Peramivir Sales Share by Country (2021-2032) Figure 66. Peramivir Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Peramivir Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Solid
Applications
  • Influenza A Treatment
  • Influenza B Treatment
Companies covered
  • BioCryst Pharmaceuticals
  • Green Cross Pharma
  • Hikma Pharmaceuticals
  • Moksha8 Pharma
  • NeoPharm
  • NT Pharma
  • SCOLR Pharma
  • Hunan Nucien Pharmaceutical Co., Ltd.
  • Merck
  • Shionogi Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Peramivir Market by Type
  3. 1.2.1 Global Peramivir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solution
  5. 1.2.3 Solid
  6. 1.3 Peramivir Market by Application
  7. 1.3.1 Global Peramivir Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Influenza A Treatment
  9. 1.3.3 Influenza B Treatment
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Peramivir Market Dynamics
  1. 2.1 Peramivir Industry Trends
  2. 2.2 Peramivir Industry Drivers
  3. 2.3 Peramivir Industry Opportunities and Challenges
  4. 2.4 Peramivir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Peramivir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Peramivir Revenue by Region
  3. 3.2.1 Global Peramivir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Peramivir Revenue by Region (2021-2026)
  5. 3.2.3 Global Peramivir Revenue by Region (2027-2032)
  6. 3.2.4 Global Peramivir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Peramivir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Peramivir Sales by Region
  9. 3.4.1 Global Peramivir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Peramivir Sales by Region (2021-2026)
  11. 3.4.3 Global Peramivir Sales by Region (2027-2032)
  12. 3.4.4 Global Peramivir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Peramivir Revenue by Manufacturers
  2. 4.1.1 Global Peramivir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Peramivir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Peramivir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Peramivir Sales by Manufacturers
  6. 4.2.1 Global Peramivir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Peramivir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Peramivir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Peramivir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Peramivir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Peramivir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Peramivir Manufacturers, Product Type & Application
  13. 4.7 Global Peramivir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Peramivir Market CR5 and HHI
  16. 4.8.2 2025 Peramivir Tier 1, Tier 2, and Tier 3
5 Peramivir Market by Type
  1. 5.1 Global Peramivir Revenue by Type
  2. 5.1.1 Global Peramivir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Peramivir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Peramivir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Peramivir Sales by Type
  6. 5.2.1 Global Peramivir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Peramivir Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Peramivir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Peramivir Price by Type
6 Peramivir Market by Application
  1. 6.1 Global Peramivir Revenue by Application
  2. 6.1.1 Global Peramivir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Peramivir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Peramivir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Peramivir Sales by Application
  6. 6.2.1 Global Peramivir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Peramivir Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Peramivir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Peramivir Price by Application
7 Company Profiles
  1. 7.1 BioCryst Pharmaceuticals
  2. 7.1.1 BioCryst Pharmaceuticals Company Information
  3. 7.1.2 BioCryst Pharmaceuticals Business Overview
  4. 7.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 BioCryst Pharmaceuticals Peramivir Product Portfolio
  6. 7.1.5 BioCryst Pharmaceuticals Recent Developments
  7. 7.2 Green Cross Pharma
  8. 7.2.1 Green Cross Pharma Company Information
  9. 7.2.2 Green Cross Pharma Business Overview
  10. 7.2.3 Green Cross Pharma Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Green Cross Pharma Peramivir Product Portfolio
  12. 7.2.5 Green Cross Pharma Recent Developments
  13. 7.3 Hikma Pharmaceuticals
  14. 7.3.1 Hikma Pharmaceuticals Company Information
  15. 7.3.2 Hikma Pharmaceuticals Business Overview
  16. 7.3.3 Hikma Pharmaceuticals Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hikma Pharmaceuticals Peramivir Product Portfolio
  18. 7.3.5 Hikma Pharmaceuticals Recent Developments
  19. 7.4 Moksha8 Pharma
  20. 7.4.1 Moksha8 Pharma Company Information
  21. 7.4.2 Moksha8 Pharma Business Overview
  22. 7.4.3 Moksha8 Pharma Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Moksha8 Pharma Peramivir Product Portfolio
  24. 7.4.5 Moksha8 Pharma Recent Developments
  25. 7.5 NeoPharm
  26. 7.5.1 NeoPharm Company Information
  27. 7.5.2 NeoPharm Business Overview
  28. 7.5.3 NeoPharm Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 NeoPharm Peramivir Product Portfolio
  30. 7.5.5 NeoPharm Recent Developments
  31. 7.6 NT Pharma
  32. 7.6.1 NT Pharma Company Information
  33. 7.6.2 NT Pharma Business Overview
  34. 7.6.3 NT Pharma Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NT Pharma Peramivir Product Portfolio
  36. 7.6.5 NT Pharma Recent Developments
  37. 7.7 SCOLR Pharma
  38. 7.7.1 SCOLR Pharma Company Information
  39. 7.7.2 SCOLR Pharma Business Overview
  40. 7.7.3 SCOLR Pharma Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SCOLR Pharma Peramivir Product Portfolio
  42. 7.7.5 SCOLR Pharma Recent Developments
  43. 7.8 Hunan Nucien Pharmaceutical Co., Ltd.
  44. 7.8.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Hunan Nucien Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Portfolio
  48. 7.8.5 Hunan Nucien Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Peramivir Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Shionogi Co.
  56. 7.10.1 Shionogi Co. Company Information
  57. 7.10.2 Shionogi Co. Business Overview
  58. 7.10.3 Shionogi Co. Peramivir Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Shionogi Co. Peramivir Product Portfolio
  60. 7.10.5 Shionogi Co. Recent Developments
8 North America
  1. 8.1 North America Peramivir Market Size by Type
  2. 8.1.1 North America Peramivir Revenue by Type (2021-2032)
  3. 8.1.2 North America Peramivir Sales by Type (2021-2032)
  4. 8.1.3 North America Peramivir Price by Type (2021-2032)
  5. 8.2 North America Peramivir Market Size by Application
  6. 8.2.1 North America Peramivir Revenue by Application (2021-2032)
  7. 8.2.2 North America Peramivir Sales by Application (2021-2032)
  8. 8.2.3 North America Peramivir Price by Application (2021-2032)
  9. 8.3 North America Peramivir Market Size by Country
  10. 8.3.1 North America Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Peramivir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Peramivir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Peramivir Market Size by Type
  2. 9.1.1 Europe Peramivir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Peramivir Sales by Type (2021-2032)
  4. 9.1.3 Europe Peramivir Price by Type (2021-2032)
  5. 9.2 Europe Peramivir Market Size by Application
  6. 9.2.1 Europe Peramivir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Peramivir Sales by Application (2021-2032)
  8. 9.2.3 Europe Peramivir Price by Application (2021-2032)
  9. 9.3 Europe Peramivir Market Size by Country
  10. 9.3.1 Europe Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Peramivir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Peramivir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Peramivir Market Size by Type
  2. 10.1.1 China Peramivir Revenue by Type (2021-2032)
  3. 10.1.2 China Peramivir Sales by Type (2021-2032)
  4. 10.1.3 China Peramivir Price by Type (2021-2032)
  5. 10.2 China Peramivir Market Size by Application
  6. 10.2.1 China Peramivir Revenue by Application (2021-2032)
  7. 10.2.2 China Peramivir Sales by Application (2021-2032)
  8. 10.2.3 China Peramivir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Peramivir Market Size by Type
  2. 11.1.1 Asia Peramivir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Peramivir Sales by Type (2021-2032)
  4. 11.1.3 Asia Peramivir Price by Type (2021-2032)
  5. 11.2 Asia Peramivir Market Size by Application
  6. 11.2.1 Asia Peramivir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Peramivir Sales by Application (2021-2032)
  8. 11.2.3 Asia Peramivir Price by Application (2021-2032)
  9. 11.3 Asia Peramivir Market Size by Country
  10. 11.3.1 Asia Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Peramivir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Peramivir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Peramivir Market Size by Type
  2. 12.1.1 SAMEA Peramivir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Peramivir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Peramivir Price by Type (2021-2032)
  5. 12.2 SAMEA Peramivir Market Size by Application
  6. 12.2.1 SAMEA Peramivir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Peramivir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Peramivir Price by Application (2021-2032)
  9. 12.3 SAMEA Peramivir Market Size by Country
  10. 12.3.1 SAMEA Peramivir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Peramivir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Peramivir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Peramivir Value Chain Analysis
  2. 13.1.1 Peramivir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Peramivir Production Mode & Process
  6. 13.2 Peramivir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Peramivir Distributors
  9. 13.2.3 Peramivir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst